ARSENAULT KAITLYN 4
4 · Skye Bioscience, Inc. · Filed Oct 30, 2024
Insider Transaction Report
Form 4
ARSENAULT KAITLYN
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-28+125,000→ 125,000 totalExercise: $5.15Exp: 2034-10-27→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.